Human equilibrative nucleoside transporter-3 (hENT3) spectrum disorder mutations impair nucleoside transport, protein localization, and stability.
about
A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variantFUN26 (function unknown now 26) protein from saccharomyces cerevisiae is a broad selectivity, high affinity, nucleoside and nucleobase transporter.Pharmacological reversal of histone methylation presensitizes pancreatic cancer cells to nucleoside drugs: in vitro optimization and novel nanoparticle delivery studiesEquilibrative nucleoside transporters-A review.The Concise Guide to PHARMACOLOGY 2013/14: transporters.Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.Purine import into malaria parasites as a target for antimalarial drug development.Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis.Accelerated coronary atherosclerosis and H syndrome.Equilibrative nucleoside transporter 1 expression in primary human hepatocytes is highly variable and determines uptake of ribavirin.Extranodal Rosai-Dorfman Disease: Clinicopathologic Series of 10 Patients With Radiologic Correlation and Review of the Literature.Inhibition of Transient Receptor Potential Channel Mucolipin-1 (TRPML1) by Lysosomal Adenosine Involved in Severe Combined Immunodeficiency Diseases.Novel homozygous SLC29A3 mutations among two unrelated Egyptian families with spectral features of H-syndrome.Lysosomal degradation of intracellular nucleic acids-multiple autophagic pathways.Identification of a novel mutation in solute carrier family 29, member 3 in a Chinese patient with H syndrome.H syndrome: 5 new cases from the United States with novel features and responses to therapy.Expression and purification of human and Saccharomyces cerevisiae equilibrative nucleoside transporters.Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3.Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.ENT3 utilizes a pH Sensing Mechanism for Transport.Defective SLC29A3 does not transport nucleosides from lysosomal lumen to cytosolAn Egyptian family with H syndrome due to a novel mutation in SLC29A3 illustrating overlapping features with pigmented hypertrichotic dermatosis with insulin-dependent diabetes and Faisalabad histiocytosis.Identification of Structural and Molecular Features Involved in the Transport of 3'-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3.A Case of SLC29A3 Spectrum Disorder-Unresponsive to Multiple Immunomodulatory Therapies.Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis.Who Is Who in Adenosine Transport.
P2860
Q21090962-7BEA86FE-2BAA-4B63-B7C2-B9C00E71EB99Q27936958-D2539B35-4DD0-465A-A386-370D2BFF90DFQ28535154-F4DC2C63-2936-49F6-B11E-9883C5B8FE83Q30244329-5352BCDD-2D42-4E27-B176-999D13F8157BQ30486743-81B3CC14-9617-4AC3-903D-5B1D14056326Q35066350-386D0705-A26D-4EB5-965E-C5BF2C43CFF8Q35513431-C8DAA681-DA37-4549-9D28-4A79621B3B23Q36714248-E1D3A4D8-F815-4EBB-9BF3-CC6689930721Q38659980-B290BDCF-B456-4D9C-934B-17F2D73CA724Q38707179-EF91CDE0-3978-449F-B3BD-0E6B8CF23717Q38709217-8805AAC2-BF89-4C13-82D5-1486B2EC7CAAQ38721360-43980E8C-61EC-4EC6-9BE4-55EB20789346Q38866060-56CD9DBD-131F-40E9-A56D-4EAC2F98C559Q39063358-3D0EE3A1-DB6C-4B7D-8959-BD81D4545195Q40126561-1E337A62-3F77-4ED4-9A20-35F7B0A6D450Q42682569-F7DE26F0-AF9E-47F5-AB3B-BA23E28D4B14Q46730885-E5B40CCD-7F83-48EC-B016-36194F04B2BBQ48516800-9159180D-EE56-4499-B2AD-8144118ED3DEQ49387560-82463BF2-E6D5-443E-A83A-7F4276AC808DQ49558478-8C2D9A45-939E-4A58-A016-44B27E4C0155Q50289017-72EFA614-F160-445A-AFF7-D7A8E6417768Q50429034-2B0133F7-2D36-4ACF-B42F-9AAB926051EAQ52659741-27E46491-74B1-4E8E-B010-9EEC33E5EDA1Q52816123-226562D3-C561-4276-8047-FC0E9D3962ECQ53394564-3BA60F35-3473-423F-A10F-DFA043210104Q55407351-D4DC401B-88B5-4A05-8180-1936B7DB7D5F
P2860
Human equilibrative nucleoside transporter-3 (hENT3) spectrum disorder mutations impair nucleoside transport, protein localization, and stability.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human equilibrative nucleoside ...... n localization, and stability.
@ast
Human equilibrative nucleoside ...... n localization, and stability.
@en
Human equilibrative nucleoside ...... n localization, and stability.
@nl
type
label
Human equilibrative nucleoside ...... n localization, and stability.
@ast
Human equilibrative nucleoside ...... n localization, and stability.
@en
Human equilibrative nucleoside ...... n localization, and stability.
@nl
prefLabel
Human equilibrative nucleoside ...... n localization, and stability.
@ast
Human equilibrative nucleoside ...... n localization, and stability.
@en
Human equilibrative nucleoside ...... n localization, and stability.
@nl
P2093
P2860
P356
P1476
Human equilibrative nucleoside ...... n localization, and stability.
@en
P2093
Ah Hyun Jun
Jashvant D Unadkat
Natarajan Kannan
Nayoung Kang
Rajgopal Govindarajan
Yangzom Doma Bhutia
P2860
P304
28343-28352
P356
10.1074/JBC.M110.109199
P407
P577
2010-07-01T00:00:00Z